As an alternative to ANGPT1-mimetics, inhibition or genetic deletion of PTPRB (VE-PTP), which negatively regulates the TEK receptor, has been studied in animal models and is currently being tested in adult patients with glaucoma. Here, ANGPT1 is linked to glaucoma.